缺乏GHSR会通过损害自而加剧帕金森病的病理
Xue Xiao1, Tingting Tang1, Mingxia Bi1
1Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders and State Key Disciplines, Physiology, School of Basic Medicine, Qingdao University, Qingdao, 266071, China.
增长激素分泌受体 (GHSR) 缺陷通过损害自和溶酶体功能,使帕金森病 (PD) 神经退行变化恶化. 恢复GHSR活动可能为PD提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元损失.
- 格林通过其受体,生长激素分泌受体 (GHSR) 保护神经元.
- GHSR在黑色物质中高度表达,但其在多巴胺基神经元中的作用尚不清楚.
研究的目的:
- 研究GHSR在帕金森病中多巴胺基神经元存活中的作用.
- 阐明GHSR缺乏加剧PD病理的分子机制.
主要方法:
- 使用了GHSR淘汰赛小鼠 (Ghsr-/-) 和一种由1-甲基-4--1,2,3,6-四胺 (MPTP) 诱导的PD模型.
- 分析了多巴胺基神经元退化,GHSR表达和活动.
- 检查了DEPTOR的表达,自标志物,溶酶体标志物和KLF4.4的表达.
主要成果:
- 在MPTP模型中,GHSR删除加剧了多巴胺基神经元退化.
- 在PD模型中,GHSR表达和活性降低.
- 缺乏GHSR导致DEPTOR过度表达,增强自开始,以及溶酶体功能障碍.
- 损坏的线粒体的清除受损,导致神经退行恶化.
- KLF4调节DEPTOR表达;KLF4敲击减轻了GHSR小鼠的神经退行.
结论:
- 内源GHSR缺乏通过损害 lysosomal 功能来损害自,从而导致帕金森病的发病.
- 在尼格拉尔多巴胺基神经元中,GHSR起着至关重要的保护作用.
- 准GHSR为帕金森病提供了一个潜在的治疗策略.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
相关概念视频
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Lysosomal Hydrolases
Neural Regulation
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
